Bristol-Myers Squibb Co (BMY)
58.15
+0.27
(+0.47%)
USD |
NYSE |
Nov 21, 15:42
Bristol-Myers Squibb Price to Book Value: 6.880 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.848 |
| November 19, 2024 | 6.890 |
| November 18, 2024 | 6.720 |
| November 15, 2024 | 6.652 |
| November 14, 2024 | 6.922 |
| November 13, 2024 | 6.911 |
| November 12, 2024 | 6.983 |
| November 11, 2024 | 7.078 |
| November 08, 2024 | 6.406 |
| November 07, 2024 | 6.473 |
| November 06, 2024 | 6.540 |
| November 05, 2024 | 6.620 |
| November 04, 2024 | 6.561 |
| November 01, 2024 | 6.427 |
| October 31, 2024 | 6.598 |
| October 30, 2024 | 6.230 |
| October 29, 2024 | 6.212 |
| October 28, 2024 | 6.228 |
| October 25, 2024 | 6.143 |
| October 24, 2024 | 6.261 |
| October 23, 2024 | 6.278 |
| October 22, 2024 | 6.243 |
| October 21, 2024 | 6.167 |
| October 18, 2024 | 6.298 |
| October 17, 2024 | 6.293 |
| Date | Value |
|---|---|
| October 16, 2024 | 6.315 |
| October 15, 2024 | 6.243 |
| October 14, 2024 | 6.232 |
| October 11, 2024 | 6.177 |
| October 10, 2024 | 6.200 |
| October 09, 2024 | 6.248 |
| October 08, 2024 | 6.210 |
| October 07, 2024 | 6.324 |
| October 04, 2024 | 6.385 |
| October 03, 2024 | 6.413 |
| October 02, 2024 | 6.361 |
| October 01, 2024 | 6.260 |
| September 30, 2024 | 6.122 |
| September 27, 2024 | 6.066 |
| September 26, 2024 | 5.972 |
| September 25, 2024 | 5.952 |
| September 24, 2024 | 6.070 |
| September 23, 2024 | 5.959 |
| September 20, 2024 | 5.887 |
| September 19, 2024 | 5.841 |
| September 18, 2024 | 5.927 |
| September 17, 2024 | 5.897 |
| September 16, 2024 | 5.956 |
| September 13, 2024 | 5.854 |
| September 12, 2024 | 5.748 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.034
Minimum
Mar 23 2020
8.520
Maximum
Dec 27 2019
4.169
Average
3.998
Median
Jun 11 2021
Price to Book Value Benchmarks
| Johnson & Johnson | 5.345 |
| Eli Lilly and Co | 49.77 |
| Merck & Co Inc | 5.678 |
| Pfizer Inc | 1.537 |
| AbbVie Inc | 50.40 |
Price to Book Value Related Metrics
| PS Ratio | 2.487 |
| Price to Free Cash Flow | 8.548 |
| Price | 58.15 |
| Earnings Yield | -6.17% |
| Market Cap | 117.94B |
| Operating PE Ratio | 16.21 |
| Normalized PE Ratio | 36.43 |